Drugs from Nature: Targets, Assay Systems and Leads

This book provides an overview of the drug discovery process from natural sources such as plants and microbes. While technological advances have streamlined the drug discovery process, enhancing the throughput and success rates, the structural features of natural products remain the primary referenc...

Full description

Saved in:
Bibliographic Details
Corporate Author: SpringerLink (Online service)
Other Authors: Haridas, Madhathilkovilakathu (Editor), Abdulhameed, Sabu (Editor), Francis, Dileep (Editor), Kumar, Swaroop S. (Editor)
Format: Electronic eBook
Language:English
Published: Singapore : Springer Nature Singapore : Imprint: Springer, 2024.
Edition:1st ed. 2024.
Subjects:
Online Access:https://doi.org/10.1007/978-981-99-9183-9
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000nam a22000005i 4500
001 978-981-99-9183-9
003 DE-He213
005 20250807145540.0
007 cr nn 008mamaa
008 240318s2024 si | s |||| 0|eng d
020 |a 9789819991839  |9 978-981-99-9183-9 
024 7 |a 10.1007/978-981-99-9183-9  |2 doi 
050 4 |a RM300-666 
072 7 |a MMG  |2 bicssc 
072 7 |a MED071000  |2 bisacsh 
072 7 |a MKG  |2 thema 
082 0 4 |a 615  |2 23 
245 1 0 |a Drugs from Nature: Targets, Assay Systems and Leads  |h [electronic resource] /  |c edited by Madhathilkovilakathu Haridas, Sabu Abdulhameed, Dileep Francis, Swaroop S Kumar. 
250 |a 1st ed. 2024. 
264 1 |a Singapore :  |b Springer Nature Singapore :  |b Imprint: Springer,  |c 2024. 
300 |a XIV, 568 p. 1 illus.  |b online resource. 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
341 0 |b Table of contents navigation  |2 onix 
341 0 |b Single logical reading order  |2 onix 
341 0 |b Short alternative textual descriptions  |2 onix 
341 0 |b Use of color is not sole means of conveying information  |2 onix 
341 0 |b Use of high contrast between text and background color  |2 onix 
341 0 |b Next / Previous structural navigation  |2 onix 
341 0 |b All non-decorative content supports reading without sight  |2 onix 
347 |a text file  |b PDF  |2 rda 
505 0 |a Chapter 1. History of therapeutic discovery from natural sources -- Chapter 2. The process of drug development from natural sources -- Chapter 3. Ayurveda-inspired reverse pharmacology in drug discovery -- Chapter 4. Contemporary approaches in drug target identification and validation -- Chapter 5. Assay systems for identification of drug leads: contemporary approaches -- Chapter 6. Computational biology in lead identification and drug development -- Chapter 7. Physiology of inflammatory responses to external and autoimmune agents of diseases -- Chapter 8. Non-steroidal anti-inflammatory drug leads from natural sources -- Chapter 9. Mechanisms of side effects of non-steroidal anti-inflammatory drugs -- Chapter 10. Therapeutic targets in cancer -- Chapter 11. Anti-neoplastic drug leads from plants and microbes -- Chapter 12. Anti-fungal, anti-bacterial, and anti-parasitic therapeutics from natural sources -- Chapter 13. Anti-viral therapeutics from plants and microbes -- Chapter 14. Cardiovascular therapeutics from natural sources -- Chapter 15. Antidiabetics and antilipemics from nature -- Chapter 16. Therapeutic targets and drug leads for reproductive health -- Chapter 17. Drug leadsfor neuro-muscular disorders from natural sources. 
520 |a This book provides an overview of the drug discovery process from natural sources such as plants and microbes. While technological advances have streamlined the drug discovery process, enhancing the throughput and success rates, the structural features of natural products remain the primary reference for small-molecule drug discovery. Focusing on the drug targets blocked/altered by natural/nature-inspired molecules, it covers how potential drug leads are screened and identified using appropriate assay systems, and the current status of drugs identified using such approaches. State-of-the-art approaches in target identification, assay development, and lead identification have also been discussed in detail. Other topics included are targets and leads in inflammation, cancer, reproductive medicine, cardiovascular and neuromuscular ailments, and infectious diseases as well as the challenges in translating drug leads into clinically viable drugs. This volume serves as a handbook for researchers in phytochemistry and drug discovery, and as a reference for researchers and students of applied biology. 
532 8 |a Accessibility summary: This PDF does not fully comply with PDF/UA standards, but does feature limited screen reader support, described non-text content (images, graphs), bookmarks for easy navigation and searchable, selectable text. Users of assistive technologies may experience difficulty navigating or interpreting content in this document. We recognize the importance of accessibility, and we welcome queries about accessibility for any of our products. If you have a question or an access need, please get in touch with us at accessibilitysupport@springernature.com. 
532 8 |a No reading system accessibility options actively disabled 
532 8 |a Publisher contact for further accessibility information: accessibilitysupport@springernature.com 
650 0 |a Pharmacology. 
650 0 |a Biotechnology. 
650 0 |a Medicine  |x Research. 
650 0 |a Biology  |x Research. 
650 1 4 |a Pharmacology. 
650 2 4 |a Biotechnology. 
650 2 4 |a Biomedical Research. 
700 1 |a Haridas, Madhathilkovilakathu.  |e editor.  |4 edt  |4 http://id.loc.gov/vocabulary/relators/edt 
700 1 |a Abdulhameed, Sabu.  |e editor.  |4 edt  |4 http://id.loc.gov/vocabulary/relators/edt 
700 1 |a Francis, Dileep.  |e editor.  |4 edt  |4 http://id.loc.gov/vocabulary/relators/edt 
700 1 |a Kumar, Swaroop S.  |e editor.  |4 edt  |4 http://id.loc.gov/vocabulary/relators/edt 
710 2 |a SpringerLink (Online service) 
773 0 |t Springer Nature eBook 
776 0 8 |i Printed edition:  |z 9789819991822 
776 0 8 |i Printed edition:  |z 9789819991846 
776 0 8 |i Printed edition:  |z 9789819991853 
856 4 0 |u https://doi.org/10.1007/978-981-99-9183-9 
912 |a ZDB-2-SBL 
912 |a ZDB-2-SXB 
950 |a Biomedical and Life Sciences (SpringerNature-11642) 
950 |a Biomedical and Life Sciences (R0) (SpringerNature-43708)